WYNNE-JONES IP CELEBRATES GROWTH WITH LAUNCH OF LONDON OFFICE

WYNNE-JONES IP CELEBRATES GROWTH WITH LAUNCH OF LONDON OFFICE

 This launch comes as the firm has achieved double digit growth for the third year running,  The continued popularity of entrepreneurial business trends such as crowd-funding has led to a surge in interest in brand and invention protection generally and increased client opportunities for Wynne-Jones IP.  Alongside this, the firm has invested heavily in recent years to secure many new, high quality IP professionals to service existing clients and to expand its portfolio, particularly in the life sciences and engineering sectors.

 

The new London office will accommodate the UK Head Office of Aipex BV, the pan-European IP law firm that Wynne-Jones IP owns in conjunction with a small number of other prominent European IP firms.  Aipex acts as regional counsel for multi-nationals and other corporates looking for a solution to the problems of developing and managing intellectual property portfolios in the multi-jurisdictional landscape of contemporary Europe.  Aipex provides a single point of entry for them to European countries, both within and without the European Union.

 

The office will be headed up by Wynne-Jones IP’s long-serving Partner and Chartered Trade Mark Attorney, Victor Caddy, who is relocating back to the capital from the firm’s Cheltenham office. He has more than twenty years’ experience as a Trade Mark and Design Attorney and Litigator.   Joining Victor will be Amelia McClure, PA to the Wynne-Jones Trade Mark team. They will be supported by the Wynne-Jones IP paralegal and administration teams and around thirty patent, trade mark and design attorneys in the UK and over two hundred throughout Europe.

 

Commenting on the opening of its first London office, Wynne-Jones IP lead Partner, Victor Caddy, said: “A year ago, we set out to launch our first London office within four years and have achieved this in less than twelve months.  This is thanks to the high quality of the team we have managing our business planning, and the dedication and enthusiasm of all our staff.

 

“Some may question our timing, with Brexit on the horizon, but I am confident that our track record of providing an excellent client experience, combined with the commercial and legal expertise for which we are renowned worldwide, will guarantee the success of the office. 

 

“Besides, Aipex is a ready-made solution to intellectual property challenges of Brexit, and, for Aipex to open a London Head Office at this time is a no-brainer”. 

Related News

news

Coronavirus - UK IPO, EPO and EU IPO extensions and support

A simple overview of the current status from IPOs. Last updated 31st March 2020. 

EPO announces extensions to deadlines due to COVID-19
news

EPO announces extensions to deadlines due to COVID-19

On Sunday 15 March 2020 the EPO published a notice advising it is invoking the provisions of Rule 134(2) EPC, and has extended all periods expiring on or after publication of the notice to 17 April 2020. This may be extended by the EPO upon publication of a further notice.

EUIPO extends all deadlines for Community Design and European Union Trade Marks
news

EUIPO extends all deadlines for Community Design and European Union Trade Marks

The Executive Director of the EUIPO has today (16 March 2020) issued a decision regarding extensions for all time limits on trade mark and design matters at the EUIPO. In accordance with the decision, all time limits expiring between 9 March 2020 and 30 April 2020 inclusive are extended until 1 May 2020.

news

UK IPO announces support for those affected by coronavirus

In brief, the UK IPO has indicated that it will use its discretionary powers (on a case-by-case basis) to extend time limits where possible under national and international law.

*Update* “EPO Board of Appeal finds Broad Institute’s CRISPR patent to lack valid priority claim and upholds revocation of patent (T 0844/18)”
news

*Update* “EPO Board of Appeal finds Broad Institute’s CRISPR patent to lack valid priority claim and upholds revocation of patent (T 0844/18)”

Earlier this year, we reported on the EPO Board of Appeal’s decision to uphold the revocation of the Broad Institute’s CRISPR patent (here). Now it appears that the Broad Institute is gearing up to put forward a petition for review by the Enlarged Board of Appeal as a last resort to save their patent.

news

The UPC is dead, long live the UPC!

European patent attorneys have been getting excited about the Unitary Patent (UP) and Unified Patent Court (UPC) for years, writing articles, and giving talks and presentations about the ins-and-outs and twists-and-turns of the whole thing. So what is the current situation? What has happened now?

UPDATE - UK IPO support for those affected by Coronavirus
news

UPDATE - UK IPO support for those affected by Coronavirus

The UKIPO has now certified that a ‘period of interruption’ began on Tuesday 24 March 2020.

aipex logo aipex logo aipex logo